fbpx
QQQ
-2.49
316.84
-0.79%
DIA
-2.00
312.11
-0.64%
SPY
-2.91
381.49
-0.77%
TLT
+ 0.60
150.62
+ 0.4%
GLD
-2.07
175.30
-1.19%

Missouri's Medical Cannabis Program Proceeding Apace

June 10, 2019 10:04 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Missouri's Medical Cannabis Program Proceeding Apace

By Peter K. Andreone, Hoban Law Group

Missouri's medical cannabis program prepared to take a giant leap forward this past week: On Tuesday, the Missouri Department of Health and Senior Services (DHSS) published its finalized rules and regulations to govern the state's medical marijuana program, as well as official application forms to obtain licensure. Updated drafts of the rules were recently published last month, and can be found at health.mo.gov. The updated drafts provide an instructive preview of what the state's final regulatory landscape will look like.

Per Missouri law, any business entity pursuing licensure must be majority-owned (51% or more) by residents of Missouri. Despite that requirement, many Missourians are eager to partner with out-of-state operators, as "prior cannabis industry experience" will be a critical factor in grading the applications and awarding licenses. Opportunities abound for out-of-state groups looking to get involved in Missouri's burgeoning medical marijuana industry. According to New Frontier Data's projections, Missouri is expected to annually generate about $111 million from medical cannabis sales by 2025.

DHSS has decided to limit the number of licenses awarded during the first year of the program. There will be 338 licenses issued statewide, including 60 cultivation licenses, 192 dispensary licenses, and 86 marijuana-infused products manufacturing licenses. In addition, DHSS has indicated that as many as 10 testing facilities could be licensed by the state. The licensing will be distributed equally among Missouri's eight congressional districts.

The application process will be highly competitive, especially for the licenses available in the major metro areas of Kansas City and St. Louis. The cities of Springfield, Columbia, Independence, St. Joseph, Joplin, and Jefferson City will also attract much attention. As of May 14, a total of 510 applicants had submitted early forms and fees, including 153 for cultivation facilities, 277 for dispensary facilities, and 80 for cannabis-infused-products manufacturing facilities. Those fees have generated over $3.67 million for the state: A geographic breakdown of pre-filed applications based on congressional district can be found at health.mo.gov.

DHSS will begin accepting completed applications for cultivation, manufacturing, dispensary, and testing facilities on August 3, and will continue to accept applications through the close of business on August 17. DHSS and its contracted partners have until December 31 to approve or deny applications.

As such, licensed medical cannabis facilities can expect to commence operations in early 2020. To date, there have been no delays in rolling out the program in Missouri, as DHSS has met all mandatory administrative deadlines. Accordingly, the early 2020 commencement date seems realistic.

Peter Andreone has over a decade of experience practicing law in the States of Missouri, Kansas, and Maryland. He serves as Counsel to Hoban Law Group and is the owner and founder of Andreone Law, a full-service civil litigation and transactional law firm based in Kansas City.

This article has been prepared for informational and general guidance purposes only; it does not constitute legal or professional advice. You should not act upon the information contained herein without obtaining specific professional advice. No representation or warranty (express or implied) is made to the accuracy or completeness of the information contained in this publication. Hoban Law Group, its members, employees, and agents accept no liability, and disclaim all responsibility, for the consequences of you or anyone else acting, or refraining to act, in reliance on the information contained in this publication or for any decision based thereupon.

The post Missouri's Medical Cannabis Program Proceeding Apace appeared first on New Frontier Data.

Image sourced from Pixabay


Related Articles

Michigan Cannabis Sales Near $1B In First Year Of Adult-Use Sales

Cannabis sales in Michigan spiked during December, bringing the total to $984.6 million for 2020. read more

Cantor Analyst Raises Aphria And Tilray Price Targets Amid Merger

Cantor Fitzgerald analyst Pablo Zuanic expressed disappointment by Aphria Inc. (TSX: APHA) (NASDAQ: APHA) quarterly results in an analyst note published Friday. read more

Cannabis Movers & Shakers: Next Green, Cannabis Control Commission, Willow, TruTrace, HEXO, Bengal Capital, MediPharm Labs, NIHC

Here is a summary of the latest leadership changes within the cannabis industry. read more

French Energy Firm Backs Hemp-Fueled Gas Plant With $23M

French energy company Qairos Energies is financing a project that will use locally grown hemp for the production of hydrogen and methane, according to HempToday. read more

Jay-Z Touts 'End Of Cannabis Prohibition' As Roc Nation Finalizes SPAC Deal With Caliva, Left Coast Ventures

A consortium made up of CMG Partners Inc., Left Coast Ventures Inc. and Shawn Carter (Jay-Z) —with his company Roc Nation — has finalized its previously announced transaction with Subversive Capital Acquisition Corp. (OTCQX: SBVCF). read more